health-austrade-logo.gif
   
Search     Click to Search
   
health-nav-health-over.gifhealth-nav-bio-over.gifhealth-nav-wellbeing-over.gif














Email Us
Enquiry form

Nucleus Network

Nucleus Network
 

Overview

Nucleus Network aims to deliver solutions to the industry for managing the bio-pharmaceutical product lifecycle. The goal is to reduce the time, risk and cost associated with the development and commercialisation of new medicines and devices.
A platform was created for clinicians and researchers to market their talents globally, while providing a shared infrastructure that would keep abreast and lead the way for excellence in clinical research performance.

Its main features include:

  • Quality driven specialized Phase I and early phase clinical research capabilities
  • 30 bed and 16 bed state-of-the-art specialized in-patient facilities with access to diverse patient and volunteer populations and specialized investigator networks.
  • All clinical trials in Australia are conducted to ICH-GCP guidelines and recognised by global regulatory authorities.
  • Nucleus Network currently conducts clinical trials for 7 of the top 10 pharmaceutical companies staff are experienced and dedicated to clinical research.
  • Continuous cardiac monitoring (telemetry) to all beds.
  • Clinical trial consulting services available to create a full clinical development plan and regulatory filings for clinical trial approval and marketing authorization for Australian and international agencies such as TGA, FDA and EMEA.

Business Opportunities (i.e Corporate Alliances/Partnerships)

Looking for opportunities to conduct early phase clinical trials for Biotech and Pharma companies. For:

  • Phase I
    • Chemical Entities
    • Biologicals
  • Pharmacokinetic
    • Oral
    • Inhaled
    • Drug Interaction
  • Patient Studies
    • First time in Patient
    • Patient Study

Technology/Products and Services Description

  • 30 + 16 bed purpose-built inpatient facilities for healthy volunteers and specialised patient groups
  • Study capabilities:
    • Proof of concept
    • First time in man
    • Patient studies
    • Pharmacokinetic/pharmacodynamic
    • Bioequivalence/ bioavailability
    • Pharmacogenomics
    • Japanese vs Caucasian metabolism
  • Preclinical GAP Analysis
  • Regulatory Development Plans
  • IND, IMP, CTX and CTN Preparation
  • Investigational Brochure and Protocol Preparation
  • Pre-IND Meeting Packages and Requests
  • Australian, EC and US Marketing Applications
  • Trial planning and management
  • Cost estimates and timelines
  • Preparation, submission of, liaison with EC
  • Data entry/management
  • Statistical services
  • Feasibility assessments
  • Consulting in pharmacokinetics

Competitive Advantages

  • Flexible and efficient regulatory system (Internationally compliant)
  • Clinical trial data acceptable to the FDA
  • Cost effective
  • Southern Hemisphere
  • Streamlining Ethics and review of multi-centre research (DHS/DIIRD)


Website address: www.nucleusnetwork.com.au


Health button - Request introduction     Health button - Back to Health B2B Portal

     

Austrade website | DFAT | Minister for TradePrivacy disclaimer | Technical info | Site disclaimer | Linking policy